ID NOW™


PLATFORM


FLEXIBLE RESPIRATORY TESTING NOW


WHEN AND WHERE YOU NEED IT


The ID NOW™ platform empowers you to make patient management decisions during the fi rst patient examination and off ers you full fl exibility to:


• Decide which test to run based on patient presentation, circulating prevalence and seasonality.


• Recentralise molecular diagnostic testing around the patient to deliver fast, actionable results at any bay or bedside.


• Transform diagnostic testing into a simple procedure with minimal training.


RSV = Respiratory Syncytial Virus


© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. COL-21166-01 09/23


The ID NOW platform provides rapid molecular respiratory testing results within minutes and with accuracy equivalent to RT-PCR.


COVID-19 | INFLUENZA A & B | RSV | STREP A


Easily integrate the ID NOW platform into your patient workfl ow, and see how the platform can save you time and costs.


IDNOW.ABBOTT


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52